The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty. The Cali Fund set out to…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
An international fund created to protect biodiversity has raised only $7,085, although it had proposed to attract about $1 billion annually. Large pharmaceutical companies, which use genetic information from nature for the development of medicines, have so far not contributed any dollars.